The healthcare services firm slashed its full-year guidance, sending its stock to the lowest level in 52 weeks.
Cencora (COR) shares dropped to a 52-week low after the company lowered its full-year earnings forecast. The revised outlook reflects weaker-than-expected performance in its pharmaceutical distribution segment, pressuring investor sentiment.
Prior to the announcement, Cencora had maintained a stable guidance range, with analysts expecting modest growth. The cut marks a sharp reversal from earlier projections, contrasting with the sector’s recent resilience amid broader market volatility.
The stock fell over 8% in early trading, underperforming peers in the healthcare services industry.